Mary Szela

Insider Reports History

Entity
Individual
Location
10835 Road To The Cure, Suite 205, San Diego, California
Signature
/s/ Barbara Chan as Attorney-in-Fact for Mary Szela
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mary Szela:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TriSalus Life Sciences, Inc. CEO AND PRESIDENT, Director Common Stock 365K Feb 13, 2024 Direct
TriSalus Life Sciences, Inc. CEO AND PRESIDENT, Director Employee Stock Option (right to buy) 289K Feb 13, 2024 Direct
Kura Oncology, Inc. Director Option to purchase common stock 26K Jun 5, 2024 Direct
Omega Therapeutics, Inc. Director Stock Option (Right to Buy) 25K Jun 20, 2024 Direct
Prometheus Biosciences, Inc. Director Common Stock 0 $108.42 Jun 16, 2023 Direct
Prometheus Biosciences, Inc. Director Stock Option (right to buy) 0 Jun 16, 2023 Direct

Insider Reports Filed by Mary Szela

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OMGA Omega Therapeutics, Inc. Jun 20, 2024 1 $0 4 Jun 21, 2024 Director
KURA Kura Oncology, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
TLSI TriSalus Life Sciences, Inc. Feb 13, 2024 2 $0 4 Feb 14, 2024 CEO AND PRESIDENT, Director
TLSI TriSalus Life Sciences, Inc. Aug 14, 2023 1 $0 4 Aug 15, 2023 CEO and President, Director
TLSI TriSalus Life Sciences, Inc. Aug 10, 2023 0 $0 3 Aug 15, 2023 CEO and President, Director
RXDX Prometheus Biosciences, Inc. Jun 16, 2023 3 $0 4 Jun 16, 2023 Director
OMGA Omega Therapeutics, Inc. Jun 7, 2023 1 $0 4 Jun 9, 2023 Director
KURA Kura Oncology, Inc. May 31, 2023 1 $0 4 Jun 2, 2023 Director
RXDX Prometheus Biosciences, Inc. May 19, 2023 1 $0 4 May 19, 2023 Director
KURA Kura Oncology, Inc. Jun 21, 2022 1 $0 4 Jun 23, 2022 Director
OMGA Omega Therapeutics, Inc. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
RXDX Prometheus Biosciences, Inc. May 19, 2022 1 $0 4 May 20, 2022 Director
OMGA Omega Therapeutics, Inc. Jul 29, 2021 0 $0 3 Jul 29, 2021 Director
KURA Kura Oncology, Inc. Jun 22, 2021 1 $0 4 Jun 23, 2021 Director